Mitigating Sociodemographic Bias in Opioid Use Disorder Prediction: A Fairness-Aware Machine Learning Framework
ABSTRACT
Background:
Opioid Use Disorder (OUD) is a critical public health crisis in the US, affecting over 5.5 million Americans in 2021. Machine learning (ML) has been used to predict patient risk of incident OUD. However, little is known about the fairness and bias of these predictive models.
Objective:
The aims of this study are two-fold: (1) to develop an ML bias mitigation algorithm for sociodemographic features, and (2) to develop a fairness-aware weighted majority voting (WMV) classifier for OUD prediction
Methods:
We used the 2020 national survey on drug and health (NSDUH) data to develop a neural network (NN) model using SGD (NN-SGD) and Adam (NN-Adam) optimizers and evaluated sociodemographic bias by comparing area under curve (AUC) values. A bias mitigation algorithm, based on equality of odds (EO), was implemented to minimize disparities in specificity and recall. Finally, a WMV classifier was developed for fairness-aware prediction of OUD.
Results:
Our bias mitigation algorithm significantly reduced bias in NN-SGD by 21.66% for gender, 1.48% for race, and 21.04% for income, and in NN-Adam by 16.96% for gender, 8.87% for marital status, 8.45% for working condition, and 41.62% for race. The fairness-aware WMV classifier achieved a recall of 85.37% and 92.68%, and an accuracy of 58.85% and 90.21% using NN-SGD and NN-Adam, respectively.
Conclusions:
The application of the proposed bias mitigation algorithm shows promise in reducing sociodemographic bias, with the WMV classifier confirming bias reduction and high performance in OUD prediction.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.